CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria

Malaria remains a significant cause of morbidity and mortality in sub-Saharan Africa. An efficacious vaccine will be an essential part of attempts to eradicate the disease. A vaccine strategy targeting multiple stages lifecycle stages may be required to achieve a high level of efficacy. In a series...

Bibliografski detalji
Glavni autori:	Ewer (nee Russell), K, Bowyer, G, Grobbelaar, A, Rampling, T, Venkatraman, N, Morelle, D, Ballou, R, Hill, A
Format:	Journal article
Izdano:	Frontiers Media 2018

Slični predmeti

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
od: Rampling, T, i dr.
Izdano: (2016)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
od: Aroosa Younis Nadeem, i dr.
Izdano: (2022-04-01)

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
od: Rampling, T, i dr.
Izdano: (2018)

RTS,S/AS01 malaria vaccine in African children.
od: Hill, A
Izdano: (2012)

A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses
od: Suresh Pallikkuth, i dr.
Izdano: (2020-04-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
od: Juliette Fortpied, i dr.
Izdano: (2020-06-01)

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
od: Rampling, T, i dr.
Izdano: (2016)

Viral vectors as vaccine platforms: from immunogenicity to impact
od: Ewer (nee Russell), K, i dr.
Izdano: (2016)

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.
od: Bertrand Lell, i dr.
Izdano: (2009-10-01)

CXCR5, the defining marker for Follicular B helper T (TFH) cells
od: Bernhard eMoser
Izdano: (2015-06-01)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
od: Mark E Polhemus, i dr.
Izdano: (2009-07-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
od: John N Waitumbi, i dr.
Izdano: (2009-11-01)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
od: Bejon, P, i dr.
Izdano: (2008)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
od: Venkatraman, N, i dr.
Izdano: (2017)

RTS,S/AS01 vaccine (Mosquirix™): an overview
od: Matthew B. Laurens
Izdano: (2020-03-01)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
od: Duncan, C, i dr.
Izdano: (2011)

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
od: Rampling, T, i dr.
Izdano: (2015)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
od: Bejon, P, i dr.
Izdano: (2009)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
od: Gosling, R, i dr.
Izdano: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
od: Roly Gosling, i dr.
Izdano: (2016-04-01)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
od: Seth Owusu-Agyei, i dr.
Izdano: (2010-01-01)

The Janus Face of Follicular T Helper Cells in Chronic Viral Infections
od: Ute Greczmiel, i dr.
Izdano: (2018-05-01)

Elevated Proportions of Circulating CXCR5+ Follicular Helper T Cells Reflect the Presence of Airway Obstruction in Asthma
od: Tsukie Kin Tsukuda, i dr.
Izdano: (2024-01-01)

Paeoniflorin improves autoimmune myocarditis in young rat by inhibiting CXCR5 to reduce follicular helper T cells
od: Chunxiao Wang, i dr.
Izdano: (2022-11-01)

CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance
od: Yuhong Chen, i dr.
Izdano: (2019-09-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
od: Seth Owusu-Agyei, i dr.
Izdano: (2009-10-01)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
od: Bejon, P, i dr.
Izdano: (2008)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
od: Hassan Mumtaz, i dr.
Izdano: (2023-06-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
od: Griffin J. Bell, i dr.
Izdano: (2020-06-01)

TCF1 Is Required for the T Follicular Helper Cell Response to Viral Infection
od: Tuoqi Wu, i dr.
Izdano: (2015-09-01)

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies
od: Mugo, RM, i dr.
Izdano: (2023)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
od: Corinne S. Merle, i dr.
Izdano: (2023-08-01)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
od: Otieno, L, i dr.
Izdano: (2019)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
od: Agnandji, S, i dr.
Izdano: (2012)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
od: Olotu, A, i dr.
Izdano: (2016)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
od: Olotu, A, i dr.
Izdano: (2013)

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
od: Abdullah Nadeem, i dr.
Izdano: (2023-01-01)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
od: Alan Brooks, i dr.
Izdano: (2012-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
od: Arora N, i dr.
Izdano: (2021-03-01)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
od: Daniel Ansong, i dr.
Izdano: (2011-04-01)